Hepatocyte-specific ablation of FASN ameliorated NAFLD and diabetes in melanocortin 4 receptor–deficient mice but not in mice with diet-induced obesity. This evidence concerns the gene FASN and metabolic dysfunction-associated steatotic liver disease.